209 related articles for article (PubMed ID: 29990486)
81. HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.
Borin TF; Zuccari DA; Jardim-Perassi BV; Ferreira LC; Iskander AS; Varma NR; Shankar A; Guo AM; Scicli G; Arbab AS
PLoS One; 2014; 9(12):e116247. PubMed ID: 25549350
[TBL] [Abstract][Full Text] [Related]
82. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
[TBL] [Abstract][Full Text] [Related]
83. RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model.
Jardim-Perassi BV; Alexandre PA; Sonehara NM; de Paula-Junior R; Reis Júnior O; Fukumasu H; Chammas R; Coutinho LL; Zuccari DAPC
Sci Rep; 2019 Jan; 9(1):966. PubMed ID: 30700756
[TBL] [Abstract][Full Text] [Related]
84. PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p.
Yu M; Liu Z; Liu Y; Zhou X; Sun F; Liu Y; Li L; Hua S; Zhao Y; Gao H; Zhu Z; Na M; Zhang Q; Yang R; Zhang J; Yao Y; Chen X
FEBS J; 2019 Mar; 286(6):1136-1153. PubMed ID: 30548198
[TBL] [Abstract][Full Text] [Related]
85. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
86. Melatonin downregulates TRPC6, impairing store-operated calcium entry in triple-negative breast cancer cells.
Jardin I; Diez-Bello R; Falcon D; Alvarado S; Regodon S; Salido GM; Smani T; Rosado JA
J Biol Chem; 2021; 296():100254. PubMed ID: 33380424
[TBL] [Abstract][Full Text] [Related]
87. Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.
Xu Q; Liu LZ; Yin Y; He J; Li Q; Qian X; You Y; Lu Z; Peiper SC; Shu Y; Jiang BH
Oncogene; 2015 Oct; 34(43):5482-93. PubMed ID: 25703326
[TBL] [Abstract][Full Text] [Related]
88. MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability.
Liu L; He J; Wei X; Wan G; Lao Y; Xu W; Li Z; Hu H; Hu Z; Luo X; Wu J; Xie W; Zhang Y; Xu N
Oncogene; 2017 Oct; 36(42):5874-5884. PubMed ID: 28628113
[TBL] [Abstract][Full Text] [Related]
89. Naloxone Counteracts the Promoting Tumor Growth Effects Induced by Morphine in an Animal Model of Triple-negative Breast Cancer.
Bimonte S; Barbieri A; Cascella M; Rea D; Palma G; Luciano A; Forte CA; Cuomo A; Arra C
In Vivo; 2019; 33(3):821-825. PubMed ID: 31028203
[TBL] [Abstract][Full Text] [Related]
90. Cold atmospheric plasma conveys selectivity on triple negative breast cancer cells both in vitro and in vivo.
Xiang L; Xu X; Zhang S; Cai D; Dai X
Free Radic Biol Med; 2018 Aug; 124():205-213. PubMed ID: 29870749
[TBL] [Abstract][Full Text] [Related]
91. miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth
Akamine T; Morodomi Y; Harada Y; Teraishi K; Tagawa T; Okamoto T; Maehara Y; Yonemitsu Y
Anticancer Res; 2018 Oct; 38(10):5693-5701. PubMed ID: 30275189
[TBL] [Abstract][Full Text] [Related]
92. In vivo validation of the functional role of MicroRNA-4638-3p in breast cancer bone metastasis.
Akshaya RL; Saranya I; Salomi GM; Shanthi P; Ilangovan R; Venkataraman P; Selvamurugan N
J Cancer Res Clin Oncol; 2024 Feb; 150(2):63. PubMed ID: 38300343
[TBL] [Abstract][Full Text] [Related]
93. A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer.
Ding L; Li J; Wu C; Yan F; Li X; Zhang S
J Mater Chem B; 2020 Apr; 8(16):3527-3533. PubMed ID: 31737891
[TBL] [Abstract][Full Text] [Related]
94. A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy.
D'Avino C; Palmieri D; Braddom A; Zanesi N; James C; Cole S; Salvatore F; Croce CM; De Lorenzo C
Oncotarget; 2016 Dec; 7(52):87016-87030. PubMed ID: 27894092
[TBL] [Abstract][Full Text] [Related]
95. A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer.
Barrow MA; Martin ME; Coffey A; Andrews PL; Jones GS; Reaves DK; Parker JS; Troester MA; Fleming JM
Breast Cancer Res; 2019 Sep; 21(1):105. PubMed ID: 31511085
[TBL] [Abstract][Full Text] [Related]
96. Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells.
Rajabi A; Saber A; Pourmahdi M; Emami A; Ravanbakhsh R; Khodavirdipour A; Khodaei M; Akbarzadeh M; Abdolahi S; Hosseinpourfeizi MA; Safaralizadeh R
Recent Pat Anticancer Drug Discov; 2020; 15(4):329-340. PubMed ID: 32990541
[TBL] [Abstract][Full Text] [Related]
97. Exosomal-microRNA transcriptome profiling of Parental and CSC-like MDA-MB-231 cells in response to cisplatin treatment.
Koh MZ; Ho WY; Yeap SK; Ali NM; Yong CY; Boo L; Alitheen NB
Pathol Res Pract; 2022 May; 233():153854. PubMed ID: 35398617
[TBL] [Abstract][Full Text] [Related]
98. Association between extract of Euphorbia szovitsii and expression level of microRNAs in MDA-MB-231 cell line.
Asadi-Samani M; Mahmoudian-Sani MR
Mol Biol Rep; 2022 May; 49(5):3531-3537. PubMed ID: 35132492
[TBL] [Abstract][Full Text] [Related]
99. A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition.
Shee K; Wells JD; Ung M; Hampsch RA; Traphagen NA; Yang W; Liu SC; Zeldenrust MA; Wang L; Kalari KR; Yu J; Boughey JC; Demidenko E; Kettenbach AN; Cheng C; Goetz MP; Miller TW
Clin Cancer Res; 2020 Jan; 26(1):159-170. PubMed ID: 31558472
[TBL] [Abstract][Full Text] [Related]
100. The Impact of microRNAs in Breast Cancer Angiogenesis and Progression.
Kontomanolis EN; Fasoulakis Z; Papamanolis V; Koliantzaki S; Dimopoulos G; Kambas NJ
Microrna; 2019; 8(2):101-109. PubMed ID: 30332982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
